Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00957541Phase 2Completed

Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device

Role: lead

NCT00528320Unknown

Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System

Role: lead

NCT00795873Completed

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

Role: lead

NCT00586378Phase 3Completed

Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study

Role: lead

All 4 trials loaded